Health Care Professionals
Conferences
Monthly Visitors
Organizers
Registrations Sold
Considerations of Bisphosphonate Therapy is organized by The Zimmer Biomet Institute (ZBI).
Accreditation: 1 CE Credit
Course Overview:
Medication-Related Osteonecrosis of the Jaw (MRONJ), first identified in 2002, adversely affects patients’ quality of life, producing significant morbidity. Cases continue to increase. It may affect patients undergoing intravenous cancer-related therapy or, more rarely, patients treated with oral or IV bisphosphonates for osteoporosis. This webinar will review current definitions of MRONJ, strategies for diagnosing, staging, and managing it, and the relevance to treatment planning dental implant therapy.
Program Description:
Medication-Related Osteonecrosis of the Jaw (MRONJ), first identified in 2002, adversely affects patients’ quality of life, producing significant morbidity. Cases continue to increase. It may affect patients undergoing intravenous cancer-related therapy or, more rarely, patients treated with oral or IV bisphosphonates for osteoporosis. This program will review current definitions of MRONJ, strategies for diagnosing, staging, and managing it, and the relevance to treatment planning dental implant therapy.
Program Objectives:
At the completion of the program, participants should be able to:
• Identify the medications associated with MRONJ, including the new antiresorptive and antiangiogenic therapies.
• Identify the risks of developing MRONJ.
• Diagnose MRONJ in patients with a history of exposure to this class of medications.
• Better understand MRONJ prevention measures and management strategies.
Additional details will be posted as soon as information is available.
Registration Name | Category | Last Date | Price |
---|---|---|---|
Early Fee | Free |